{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T08:16:03Z","timestamp":1794989763089,"version":"4.9.1"},"reference-count":17,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/1744666x.2026.2731960","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:53:25Z","timestamp":1788911605000},"page":"971-974","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Atacicept in IgA nephropathy"],"prefix":"10.1080","volume":"22","author":[{"given":"Sheila A.","family":"Doggrell","sequence":"first","affiliation":[{"name":"Gold Coast Campus, Griffith University","place":["Southport, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2510198"},{"key":"e_1_3_3_3_1","unstructured":"ClinicalTrials.gov. Atacicept in subjects with IgA nephropathy (ORIGIN 3). [cited 2026 May 5]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04716231?cond=IgA%20Nephropathy&intr=Atacicept&viewType=Card&rank=2"},{"key":"e_1_3_3_4_1","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. IgA nephropathy. [cited 2026 Jun 17]. Available from: https:\/\/www.niddk.nih.gov\/health-information\/kidney-disease\/iga-nephropathy"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad146"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2025.1545329"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-019-00575-7"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.05.017"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.03.012"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000541"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf203"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2512133"},{"key":"e_1_3_3_13_1","unstructured":"ClinicalTrials.gov. A rollover study to evaluate the long-term safety and efficacy of atacicept (ORIGIN EXTEND). [cited 2026 Jun 13]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06674577?cond=IgA%20Nephropathy&intr=Atacicept&viewType=Card&rank=4&tab=researcher"},{"key":"e_1_3_3_14_1","unstructured":"ClinicalTrials.gov. Monthly dosing of atacicept in IgAN. [cited 2026 Jun 13]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07020923?cond=IgA%20Nephropathy&intr=Atacicept&viewType=Card&rank=3#more-information"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.12.014"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2514415"},{"key":"e_1_3_3_17_1","unstructured":"ClinicalTrials.gov. An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases (RUBY-3). [cited 2026 Jun 29]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05732402?intr=Povetacicept&viewType=Card&rank=3"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2025.10.029"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2026.2731960","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/1744666X.2026.2731960","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2026.2731960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:22:59Z","timestamp":1794986579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2026.2731960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/1744666X.2026.2731960"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2026.2731960","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}